PMDA drug package insert
オビドレル皮下注シリンジ250μg
PMDA Prescription drug · メルクバイオファーマ株式会社 · package insert Apr 7, 2026
Key facts
| Brand names | オビドレル皮下注シリンジ250μg |
|---|---|
| Nonproprietary names | コリオゴナドトロピン アルファ（遺伝子組換え） |
| Companies | 製造販売元／メルクバイオファーマ株式会社, 供給元／Merck Serono S.A.（スイス） |
| Product type | Prescription drug |
| Therapeutic category | 遺伝子組換えヒト絨毛性性腺刺激ホルモン製剤 |
| Therapeutic category codes | 872413 |
| YJ codes | 2413406G1020 |
| Approval numbers | 22800AMX00686000 |
| Package insert edition | 第5版 |
| Package insert date | Apr 7, 2026 |
| PMDA document key | 380079_2413406G1020_1 |
| PMDA company code | 380079 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: